InsidersTradesSigma
Total declarations
Companies
▲ Purchases (14 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
14
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-12.6%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by LUCIER GREGORY T, Director. Director active across 8 companies, notably Maravai Lifesciences Holdings, INC.. Aggregated, 61 disclosures have been recorded. Breakdown: 14 buys · 2 sells. Total volume traded: €3.5m. History available since 30 April 2021. The latest transaction was filed on 5 December 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations61 total
51,472 shares@ US$3.7050.0% of flowClass A Common StockSEC:0001251299-25-000004
Ideal exit: 1 Sept 2026 (T+270)
51,472 shares@ US$3.700.035% mcap50.0% of flowClass A Common StockSEC:0001251299-25-000004:0
Ideal exit: 1 Sept 2026 (T+270)
8,736 shares0Common StockSEC:0001722482-25-000218:0
127.222 shares0Common StockSEC:0001127602-25-012077:0
15,142 shares@ US$16.5122.0% of flowCommon StockSEC:0001127602-25-007590:0
Ideal exit: 28 Nov 2025 (T+270)
5,000 shares@ US$18.36998.0% of flowCommon StockSEC:0001127602-25-002340:0
Ideal exit: 15 Aug 2025 (T+270)
99.446 shares0Common StockSEC:0001127602-25-001223:0
36,914 sharesCommon StockSEC:0000950170-24-137720:0
20,645 shares0Class A Common StockSEC:0001823239-24-000128:0
1,000 shares@ US$18.27931.6% of flowCommon StockSEC:0001127602-24-027492:0
Ideal exit: 12 Aug 2025 (T+270)
4,663 shares0Common StockSEC:0001596783-24-000099:0
69.221 shares0Common StockSEC:0001127602-24-025511:0
8,212 shares@ US$24.352516.8% of flowCommon StockSEC:0001127602-24-021933:0
Ideal exit: 5 May 2025 (T+270)
74.688 shares0Common StockSEC:0001127602-24-020397:0
3,577 shares@ US$27.94988.4% of flowCommon StockSEC:0001127602-24-017281:0
Ideal exit: 25 Feb 2025 (T+270)
20,645 shares@ US$10.7838.6% of flowClass A Common StockSEC:0001823239-24-000071:0
11,628 shares0Common StockSEC:0001127602-24-016574:0
26.426 shares0Common StockSEC:0001127602-24-012905:0
21.479 shares0Common StockSEC:0001127602-24-001315:0
10,000 shares@ US$31.4426.4% of flowCommon StockSEC:0001127602-23-028291:0
Ideal exit: 18 Aug 2024 (T+270)
6,993 shares0Common StockSEC:0001596783-23-000147:0
48.731 shares0Common StockSEC:0001127602-23-025915:0
70,000 sharesCommon StockSEC:0000899243-23-019719:0
24,000 shares0Class A Common StockSEC:0001823239-23-000060:0
41.45 shares0Common StockSEC:0001127602-23-020833:0
25 of 61 declarations
About LUCIER GREGORY T
Gregory T Lucier is a director at Maravai Lifesciences Holdings, Inc.
